Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia

被引:83
作者
Corcoran, MM
Rasool, O
Liu, Y
Iyengar, A
Grander, D
Ibbotson, RE
Merup, M
Wu, XS
Brodyansky, V
Gardiner, AC
Juliusson, G
Chapman, RM
Ivanova, G
Tiller, M
Gahrton, G
Yankovsky, N
Zabarovsky, E
Oscier, DG [1 ]
Einhorn, S
机构
[1] Royal Bournemouth Gen Hosp, Mol Biol Lab, Bournemouth BH7 7DW, Dorset, England
[2] Karolinska Hosp, Radiumhemmet, S-10401 Stockholm, Sweden
[3] Huddinge Hosp, Dept Med, S-14186 Huddinge, Sweden
[4] Russian Acad Sci, Inst Gen Genet, Genome Anal Lab, Moscow, Russia
[5] Karolinska Inst, Microbiol & Tumorbiol Ctr, Stockholm, Sweden
关键词
D O I
10.1182/blood.V91.4.1382
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A region of chromosome 13q14.3, telomeric to the Retinoblastoma gene RB-1 is frequently deleted in patients with B-cell chronic lymphocytic leukemia (B-CLL). A cosmid and P1-derived artificial chromosome (PAC) contig spanning over 600 kb has been constructed, which encompasses this locus. The contig clones have been used to order a number of markers along the minimally deleted region and to localize a series of CpG islands corresponding to possible candidate genes. A novel polymorphic dinucleotide repeat, 6E3.2, present in one of the ordered cosmid clones has been isolated for use in deletion mapping studies of patient DNA. Leukemic samples from 229 CLL patients have been screened for loss of heterozygosity using microsatellite markers and analyzed for hemizygous and homozygous deletions by Southern blot techniques using genomic probes selected from cosmids across the region. Hemizygous deletions were found in 31% of cases with an additional 10% showing homozygous loss. The use of these probes has defined the commonly deleted area to less than 130 kb, centromeric to the locus D13S272. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:1382 / 1390
页数:9
相关论文
共 42 条
[1]  
BELLANNECHANTEL.C, 1991, NUCLEIC ACIDS RES, V19, P550
[2]  
Brodyanskii VM, 1995, MOL BIOL+, V29, P665
[3]   EVIDENCE FOR A NEW TUMOR SUPPRESSOR LOCUS (DBM) IN HUMAN B-CELL NEOPLASIA TELOMERIC TO THE RETINOBLASTOMA GENE [J].
BROWN, AG ;
ROSS, FM ;
DUNNE, EM ;
STEEL, CM ;
WEIRTHOMPSON, EM .
NATURE GENETICS, 1993, 3 (01) :67-72
[4]   Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia [J].
Bullrich, F ;
Veronese, ML ;
Kitada, S ;
Jurlander, J ;
Caligiuri, MA ;
Reed, JC ;
Croce, CM .
BLOOD, 1996, 88 (08) :3109-3115
[5]  
CHAPMAN RM, 1994, ONCOGENE, V9, P1289
[6]  
Corcoran M., 1996, Blood, V88, p358A
[7]   THE DISTRIBUTION OF CPG ISLANDS IN MAMMALIAN CHROMOSOMES [J].
CRAIG, JM ;
BICKMORE, WA .
NATURE GENETICS, 1994, 7 (03) :376-382
[8]   CHRONIC LYMPHOCYTIC LEUKEMIA - AN ACCUMULATIVE DISEASE OF IMMUNOLOGICALLY INCOMPETENT LYMPHOCYTES [J].
DAMESHEK, W .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1967, 29 (4P2) :566-&
[9]  
DANIELS RJ, 1991, HUMAN GENE MAPPING, V11, P1894
[10]  
DEVILDER MC, 1995, CANCER RES, V55, P1355